MARKET

ANL

ANL

Adlai Nortye Group Ltd
NASDAQ
15.53
-0.30
-1.90%
Closed 19:30 09/25 EDT
OPEN
16.16
PREV CLOSE
15.83
HIGH
16.16
LOW
15.38
VOLUME
34.80K
TURNOVER
67.82K
52 WEEK HIGH
17.25
52 WEEK LOW
0.8786
MARKET CAP
1.00B
P/E (TTM)
-139.0331
1D
5D
1M
3M
1Y
5Y
1D
Major Insider Move Shakes Up Adlai Nortye Sponsored ADR
TipRanks · 3d ago
Weekly Report: what happened at ANL last week (0914-0918)?
Weekly Report · 09/21 09:20
Weekly Report: what happened at ANL last week (0907-0911)?
Weekly Report · 09/14 09:21
Adlai Nortye Group Price Target Announced at $31.00/Share by Jefferies
Dow Jones · 09/10 12:29
Jefferies Initiates Coverage On Adlai Nortye with Buy Rating, Announces Price Target of $31
Benzinga · 09/10 12:19
Adlai Nortye initiated with a Buy at Jefferies
TipRanks · 09/10 10:21
Adlai Nortye Price Target Maintained With a $20.00/Share by HC Wainwright & Co.
Dow Jones · 09/08 16:06
HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $20 Price Target
Benzinga · 09/08 15:57
More
About ANL
Adlai Nortye Group Ltd. is a clinical-stage biotechnology company. The Company is engaged in the research and development of pharmaceutical products. It is developing targeted and immune-modulating cancer therapies. Its RAS-targeting portfolio includes AN9025, an oral pan-RAS(ON) inhibitor for RAS-driven cancers, and AN4035, a CEACAM5-targeting antibody-drug conjugate (ADC) delivering a potent pan-RAS(ON) inhibitor directly to tumors. It is also developing cancer immunotherapies, including AN8025, a tri-functional fusion protein (aPD-L1 × CD86 variant × LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005, a first-in-class oral small-molecule PD-L1 inhibitor, which are designed to activate cancer immunity in novel ways. Its pipeline also includes AN0025, a small molecule EP4 antagonist designed to modulate the tumor microenvironment.

Webull offers Adlai Nortye Group Ltd (ADR) stock information, including NASDAQ: ANL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANL stock methods without spending real money on the virtual paper trading platform.